Multi arm Optimization of Stroke Thrombolysis (MOST): a blinded, randomized controlled adaptive, multi arm, adjunctive thrombolysis efficacy trial in ischemic stroke.

Gender
Any

Age Group
Any

At a Glance

IRB#CIRB19-0678

Lead PhysicianChristopher Lawrence Kramer

Collaborator(s)N/A

EligibilityRecruiting